Member Info for MIKODX

I'm surprised the elephant in the room didn't get a mention, so maybe someone on here can explain. What's the latest with this Takeover bid?

If you look at the drug development process in the below link, you will see that GDR are now at the Post Marketing Surveillance stage, which is the the final stage of the process. GDR also have the stroke test which is being assessed by NICE, with the final outcome being announced and published in July. FDA approval is also in the pipeline. Lots of exciting news to come. Under no circumstances should this company be selling itself short.

https://mstrust.org.uk/a-z/drug-development-process

If they sold the shares for 3p, then the dilution will not be so enormous. Either sell at that price or not at all.

Whose bright idea was it to sell the Placing shares at a 50% discount? Now they've just shaved off 100% of the companies market value. Mr Cheek is a moron for allowing this to happen. This should be voted a firm no at the GM. I'm aware that a Placing is going to be neccessary, but the company should not be giving away the shares. This company has great products that are already being used within the NHS. If Mr Cheek in his short reign, is already selling the company short, then he needs to be removed immediately. The Placing price should have been the same as the SP on the day of the announcement. If it had, then we wouldn't have dropped so low. The BOD are totally incompetent at this point, this should be voted a firm NO.

Mr Cheek has officially ruined this once decent company. He must be feeling very proud of himself.

The company is also in the middle of an FSP. Why isn't there any updates on that front? This is an important period the company is going through, this should be top of the agenda. Instead they've gone all quiet, and in the meantime heavily diluted the company.

So you’re telling me 20M shares has caused a 30% drop in the SP? Something not quite right with the AIM market. Big ripoff if you ask me. MM’s taking the p…

Having been in stocks that have been in similar situation as this one, my advice to anyone invested, is believe what the company has told you so far. Don’t get sucked into the conspiracy theories being mentioned on this board. The company hasn’t mentioned anything about secret buyers, or potential secret buyers in their last RNS. What you do know is that the company is about to be taken private, and that the shares will be delisted. Make your decisions based on your own research, and go over every last detail in that last RNS with a fine tooth comb.

GL.

I fully understand why some feel the company could go private. In the Presentation Q&A, when asked if the company could go private, the CEO replied "no comment", and when asked again, he said he doesn't want to comment on it. That was very very telling. But I agree, the company has huge potential and sales have increased substantially lately. If we can expand to another fifteen or so sites, then we can start dreaming bigger.

100M? The company can’t even generate 1M yet, calm down. Let’s get to the first million before taking about hundreds of millions.

Mountainous - I’m glad you didn’t invest too much over here, it’s always better to lose a little than lose the lot. The AIM is probably the most dangerous market in the world right now, mostly caused by the state of the economy. If one wants to survive in this wild market, you have to get in at the right time and more importantly, get out at the right time. Better to stay with the safe stocks that are financially stable and are generating income. If one is going to play around with stocks that are spending more than they are earning, and have a small MCAP, you have to proceed with the utmost caution. You can’t be dithering when it’s time to get out, always remember it drops just as fast as it rises.

Listen, I feel your pain, same thing happened over at CINE. These AIM stocks is no joke, you can get wiped out in an instant. The companies on AIM don't give a fig about shareholders. The amount of debt this company had should have been a warning. Yet you still had some on here saying the business was worth 500M, utter rubbish. Dont ever listen to the rampers, dyor and if you smell a rat or the books looks cooked, get the hell out as fast as you can. Which is why I scarpered with a small loss when I heard there was no guarantee that a takeover will happen. I smelt a rat immediately, and it became clear what game the company was playing. So I sold and glad I did, f... em, they dont give a f... so why should you.

Silverblade - I agree the dilution is bad, but it's gone from 95M - 120M not 150M. Still not too bad, and the latest dilution should be the last. The company now has enough money to keep the lights on and see out the Takeover bid.

I've only invested in RENX because it has the KidneyIntelX platform which is FDA approved and being used and fully funded by Medicare. It's also being used by major United States Insurance companies and multiple state Blue Cross Blue Shield organizations. RENX has huge potential and could be about to be taken over by a big pharmaceutical company. That's the only reason I'm here, If it was because of it finances, I would have stayed well clear of this company, it burns through far too much cash. This Takeover has possibly come at just the right time.

GDR are flat broke and will be seeking funding very soon, as early as the coming weeks or days. I think Mr Cheek will have something up his sleeve regarding funding. I see a big player stepping in to finance the company. The company's product is already being rolled out within the NHS, with the stroke test following closely behind. Genedrive may be low on cash but they certainly have sound fundamentals and great prospects. I see things changing in a big way in the coming weeks and months.

Need to keep up with the news, it's rebounded back to 64K. Obviously a knee-jerk reaction to escalated tensions in the ME.

Used to make some good returns from this stock in the Covid days. But the writing was on the wall and I got out before it started heading down. I've learnt from this stock, when investing in a company, make sure to go over their financials with a fine tooth comb, and keep an eye on it regularly. If their accounts doesn't look good or looks very shady, make as much profit as you can and get the hell out of the stock fast. Thats how you've got to treat AIM stocks, even if it means taking a loss, just take as small a loss as you can and get the hell out fast. AIM stocks is no joke especially the way the UK economy is at the moment.

Trickymatters - Too right, we really should be around the 35p mark, just a couple of pennies short. But it's to be expected as the UK are currently in the middle of a recession. Used to be able to get almost two dollars to the pound, now the dollar has almost the same value as the pound.

1x ADS is equivalent to 2x UK shares.

Looks like this is sticking around the 30 mark until we get some Takeover news. I’ll take that.

Having had time to digest the Presentation and the Interim reports, things overall are looking good for the company. We have the AIHL and CYP2C19 being tested and used in clinical settings. According to the latest reports revenue has increased tenfold from 21K previous six months, to 240K. Which means the yearly turnover will be in the region of half a million. That's a big improvement. This will be money that has been generated from the roughly 14 AIHL sites. Slow but steady improvements is good to see. With the CYP2C19 about to be recommended I see nothing but positive news coming in 2024.

Obviously funds will have to be raised, but as long as it's to help fund FDA and help with the AIHL expansion, it will be money well spent. The biggest fear is obviously the share dilution that will be caused having to raise the funds. Hopefully the company will take that into consideration. The telling thing for me though in the Presentaion, was when Mr Cheek became very cagey when asked if the company will be taken private. Mr Cheek blatantly swerved the question and refused to make any comment on it, that was very telling. But overall GDR still has solid fundamentals in place and with their foot already in the NHS door and FDA to come, things can only get better.